How long does it take to lose 2 stone on Wegovy?

The dose schedule shapes your timeline more than most people expect

Wegovy isn't taken at its full therapeutic strength from day one. Treatment starts at 0.25mg and steps up through 0.5mg, 1.0mg and 1.7mg before reaching 2.4mg, with around four weeks at each level. That titration period (roughly four months) is designed to let your body adapt gradually, reducing the nausea and digestive discomfort that can accompany GLP-1 medicines. During this phase, weight loss is real but often modest. The meaningful acceleration tends to come once you're settled at 2.4mg.

This matters for expectation-setting. If you start in January, you're unlikely to be at your cruising dose until late April or May. Worth bearing that in mind if you're timing a course around a holiday or a specific goal date, building in the titration window before expecting the full effect is a realistic way to plan. You can read more about the broader picture on how long weight loss takes on Wegovy.

The MHRA approved a higher 7.2mg dose in early 2026, and early trial data suggest around 20.7% average loss over 72 weeks at that level, closer to tirzepatide's results. Whether that dose is appropriate for any individual is a clinical decision.

Starting weight, metabolic health and lifestyle all shift the calculation

Two stone means something different depending on where you start. For someone at 20 stone, it's 10% of their body weight; for someone at 13 stone, it's closer to 22%. Since Wegovy tends to produce percentage-based reductions, the heavier starting point often means reaching the 2-stone mark faster in calendar time, even though the percentage is smaller.

Metabolic factors matter too. People with insulin resistance, thyroid conditions, or significant cardiovascular disease may find their weight responds differently to appetite suppression alone. That's not a failure of the medicine; it's a reason why the initial weeks of Wegovy look different from person to person.

Nutrition and activity alongside treatment make a real difference. The trial evidence comes from participants following a reduced-calorie diet and increased physical activity, Wegovy isn't designed to work in isolation, and the prescriber's advice on lifestyle support is part of the clinical picture. The NHS England guidance on weight-management injections is clear that these medicines work best alongside behavioural support.

What an honest 2-stone timeline looks like in practice

For most people, a realistic working estimate is six to eight months from first injection to 2 stone lost, assuming consistent use, good tolerance, and a starting BMI where 2 stone represents 12–18% of body weight. Some reach it in five months. Others take closer to ten or twelve, particularly if dose increases are slowed by side effects or if there are medical factors in play.

The non-linear pattern catches people out. A fast first few weeks (partly water, partly the early appetite suppression) is common. A plateau around months three or four, when the body has partially adjusted to the new intake but hasn't yet reached maintenance dose, is also normal. Progress almost always resumes. If you're wondering how long you need to take Wegovy to see results, a slower patch is rarely a sign something has gone wrong, though it's worth raising with your prescriber rather than guessing. For a comparison with reaching a smaller target, the one-stone timeline page covers that phase in more detail.

If 2 stone feels like a stepping stone rather than the end-point (because you're aiming for 3 or more) the 3-stone Wegovy timeline is a useful next read.

What the prescriber is watching while you lose weight

A legitimate course of Wegovy involves more than receiving pens and counting weeks. A prescriber reviews whether the treatment is working, whether side effects are manageable, and whether the dose should continue at the current level or increase. That review happens before every repeat at a regulated service. If weight loss falls below 5% after six months on the maintenance dose, clinical guidance suggests reassessing whether continuing is appropriate, a consideration the NICE recommendation for semaglutide (TA875) is explicit about.

Common side effects are gastrointestinal (nausea, loose stools, constipation, reflux) and tend to be worst during or just after a dose increase, settling over a week or two in most cases. Staying well hydrated and eating smaller portions helps. The full Wegovy overview covers the side-effect profile in more detail, and the Patient Information Leaflet that comes with every pen is the definitive reference for what to watch for and when to seek help.

If you'd like your own situation reviewed by a real prescriber rather than working from averages, speak to our prescribers through a free consultation, same-day clinical review, no waiting list, and all the context that a one-size number can't give you.